EndoGastric Solutions Announces New Data Confirming the Efficacy of Concomitant Hiatal Hernia Repair and TIF 2.0 Procedure in Providing Symptom Control for GERD Patients »
September 5, 2019
A 99-patient study confirms that a laparo-endoluminal approach reduces proton pump inhibitor medication use and significantly improves quality-of-life scores REDMOND, Wash – EndoGastric Solutions® today announced the publication of new clinical data confirming that concomitantly performed hiatal hernia (HH) repair and the Transoral Incisionless Fundoplication (TIF® 2.0) procedure using the EsophyX® device, is an effective […] More »
DDW 2019 report on TIF procedure data presented »
June 20, 2019
EndoGastric Solutions Takes the Stage at DDW, World’s Largest Gathering of GI, Hepatology, and Endoscopy Specialists Adrian Lobontiu, MD, FACS, Chief Medical Officer of EndoGastric Solutions Each year, leading researchers and clinicians in the fields of gastroenterology, hepatology, and endoscopy gather at Digestive Disease Week® (DDW®) to share cutting-edge data and gain insights into the […] More »
EndoGastric Solutions Closes Series I Financing at a Total of $45 Million »
May 28, 2019
Participation of Accelmed, a leading medical device investor, validates the compelling market potential of the company’s EsophyX technology REDMOND, Wash. – May 28, 2019 – EndoGastric Solutions® today announced the closing of its Series I financing at a total of $45 million. Accelmed, a leading growth capital medical device investor, joined the round, which had […] More »
- 1
- 2
- 3
- …
- 16
- Next Page »